Evidence mapPaperPMID 38600540Full record

ArticleBMC public health2024

Implementation of COVID-19 vaccination services in prison in six European countries: translating emergency intervention into routine life-course vaccination.

Sara Mazzilli, Nicola Cocco, Davide Petri, Babak Moazen, Alicia Rosello, Jemima D'Arcy, Emma Plugge, Laura Baglietto, Eva Murauer, Heino Stöver and 11 more

Open access · goldAbstract read
In one paragraph

Article in BMC public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 9 institutions in 5 countries.

Sara Mazzilli *Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
Nicola Cocco *Infectious Diseases Service, Penitentiary Health System, Azienda Socio-Sanitaria Territoriale Santi Paolo e Carlo, Milan, Italy.
Davide PetriDepartment of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
Babak MoazenDepartment of Health and Social Work, Institute of Addiction Research (ISFF), Frankfurt University of Applied Sciences, Frankfurt/Main, Germany.
Alicia RoselloUK Health Security Agency, London, UK.
Jemima D'ArcyUK Health Security Agency, London, UK.
Emma PluggePrimary Care, Population Sciences and Medical Education, Faculty of Medicine, University of Southampton, Southampton, UK.
Laura BagliettoDepartment of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Eva MurauerHealth Unit of the Villeneuve-les-Maguelone prison, University Hospital Centre Montpellier, Montpellier, France.
Heino StöverDepartment of Health and Social Work, Institute of Addiction Research (ISFF), Frankfurt University of Applied Sciences, Frankfurt/Main, Germany.
Tassos TrattonikolasMinistry of Justice and Public Order - Cyprus Prison Department, Nicosia, Cyprus.
Iakovos StylianouMinistry of Justice and Public Order - Cyprus Prison Department, Nicosia, Cyprus.
Svetlana DoltuAct For Involvement, Chișinău, Republic of Moldova.
Vladislav BusmachiuNational Administration of Penitentiaries, Chișinău, Republic of Moldova.
Josefina MavrouCyprus National Addictions Authority, Nicosia, Cyprus.
Ioanna YiasemiCyprus National Addictions Authority, Nicosia, Cyprus.
Irina BarbirosNational Administration of Penitentiaries, Chișinău, Republic of Moldova.
Filipa Alves da CostaHealth in Prisons Programme, WHO Regional Office for Europe, Copenhagen, Denmark.
Fadi MerouehHealth Unit of the Villeneuve-les-Maguelone prison, University Hospital Centre Montpellier, Montpellier, France.
Roberto RanieriInfectious Diseases Service, Penitentiary Health System, Azienda Socio-Sanitaria Territoriale Santi Paolo e Carlo, Milan, Italy.
Lara TavoschiDepartment of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy. lara.tavoschi@unipi.it.
University of Pisa · ITMinistry of Education and Culture · CYUK Health Security AgencyAzienda Socio Sanitaria Territoriale Lariana · ITAzienda Socio Sanitaria Territoriale Santi Paolo e CarloGoethe University Frankfurt · DEUniversity Hospital Heidelberg · DEUniversity of Southampton · GBWorld Health Organization Regional Office for Europe · DK

Funding

Third Health Programme 101018353World Health Organization 001
6 · The paper itself

Abstract

backgroundEvidence has shown that the risk of transmission of SARS-CoV-2 is much higher in prisons than in the community. The release of the COVID-19 vaccine and the recommendation by WHO to include prisons among priority settings have led to the inclusion of prisons in national COVID-19 vaccination strategies. Evidence on prison health and healthcare services provision is limited and often focuses on a single country or institution due to the multiple challenges of conducting research in prison settings. The present study was done in the framework of the EU-founded project RISE-Vac. It aimed to analyse the best practices and challenges applied in implementing COVID-19 universal vaccination services during the pandemic to support future expansion of routine life course vaccination services for people living in prison (PLP).

methodsTwo online cross-sectional surveys were designed and piloted: survey1 on prison characteristics and (non-COVID-19) immunisation practices; survey2 on the implementation and coverage of COVID-19 vaccination with open-ended questions for thematic analysis. Each RISE-Vac project partner distributed the questionnaire to one or two prisons in their country. Answers were collected from eight European prisons' directors or medical directors between November 2021-May 2022.

resultsAccording to our findings, the implementation modalities of COVID-19 vaccination services in the surveyed prisons were effective in improving PLP vaccination coverage. Strategies for optimal management of the vaccination campaign included: periodic time slot for PLP vaccination; new staff recruitment and task shifting; distribution of informational material both to PLP and prison staff. Key challenges included continuity of care after release, immunisation information system, and vaccine hesitancy.

conclusionsTo the best of our knowledge, this is the first study describing the implementation of COVID-19 vaccination services in European prisons, suggesting that the expansion of vaccination provision in prison is possible. There is no unique solution that will fit every country but commonalities likely to be important in the design and implementation of future vaccination campaigns targeting PLP emerged. Increased availability of vaccination services in prison is not only possible, but feasible and highly desirable, and can contribute to the reduction of health inequalities.

Indexed as

COVID-19PrisonersCOVID-19 VaccinesCross-Sectional StudiesHumansLife Change EventsPrisonsSARS-CoV-2VaccinationCOVID-19 VaccinesCOVID-19EuropeHealth inequitiesPrisonVaccination

Identifiers

PMID38600540
PMCPMC11007954
OpenAlexW4394681273

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.